No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Haematologica Année : 2018

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy

1 Uppsala Universitet [Uppsala]
2 Uppsala University
3 IGP - Department of Immunology, Genetics and Pathology [Uppsala, Sueden]
4 Department of Hematology [Uppsala]
5 Institute of Applied Biosciences, Centre for Research and Technology-Hellas, Thessaloniki, Greece;
6 Università Vita-Salute San Raffaele, Milan, Italy.
7 Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy
8 Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
9 Università Vita e Salute
10 Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
11 Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
12 The Feinstein Institute for Medical Research
13 CEITEC-Central European Institute of Technology, MasarykBrno, Czech Republic.
14 CEITEC MU - Central European Institute of Technology [Brno]
15 Erasmus MC - Erasmus University Medical Center [Rotterdam]
16 Department of Hematology, Rigshospitalet, Copenhagen, Denmark
17 First Department of Propaedeutic Medicine, University of Athens, Athens, Greece
18 The Feinstein Institute for Medical Research
19 Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
20 Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
21 Karolinska University Hospital [Stockholm]
22 IGH - Institut de génétique humaine
23 CHU Pitié-Salpêtrière [AP-HP]
24 Hematology and Transplantation
25 Skane University Hospital [Lund]
26 Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
27 Unipd - Università degli Studi di Padova = University of Padua
28 VIMM - Venetian Institute Molecular Medicine
29 Department of Hemato-Oncology, Belfast City Hospital, Belfast, UK
30 University Hospital Brno
31 Department of Immunology, Mayo Clinic, Rochester, MV, USA
32 Mayo Clinic [Rochester]
33 Hematology Department, Nikea General Hospital, Piraeus, Greece
34 Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
35 Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
36 Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
37 Institute of Applied Biosciences, Thessaloniki, Greece.
Véronique Giudicelli
Marie-Paule Lefranc

Dates et versions

hal-01777880 , version 1 (25-04-2018)

Identifiants

Citer

Panagiotis Baliakas, Mattias Mattsson, Anastasia C Hadzidimitriou, Eva Minga, Andreas C Agathangelidis, et al.. No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy. Haematologica, 2018, 103 (4), pp.e158 - e161. ⟨10.3324/haematol.2017.182634⟩. ⟨hal-01777880⟩
91 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More